Allogene Therapeutics Inc ALLO Valuation Ratios and Share Stats

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Allogene Therapeutics Inc (ALLO)
Allogene Therapeutics Inc (ALLO) Financials

Allogene Therapeutics Inc (ALLO)

1.795

-0.11

( -5.77% )

Updated: 11:55:48

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	N/A	-54.663	-24.75	-25.721	-22.679	-35.85	-44.833
Return on Equity (%)	200	-60.158	-27.713	-29.289	-25.752	-42.045	-55.558
Return on Invested Capital (%)	200	-81.109	-39.006	-36.507	-36.88	-60.761	-59.019
Operating Margin (%)	N/A	N/A	N/A	N/A	-667.736	-136885.597	-344489.474
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-667.736	-136885.597	-344489.474
Book Value Per Share	N/A	5.782	5.061	7.686	6.425	4.61	3.044
Earnings Per Share	N/A	-1.741	-1.485	-1.781	-1.802	-2.303	-1.945
Cash Per Share	N/A	0.761	1.409	1.305	1.215	0.429	0.494
Working Capital Per Share	N/A	3.61	4.116	5.345	2.967	3.284	2.508
Operating Profit Per Share	N/A	N/A	N/A	N/A	0.27	0.002	0.001
EBIT Per Share	N/A	-1.742	-1.488	-1.781	-1.802	-2.303	-1.945
EBITDA Per Share	N/A	-1.742	-1.488	-1.781	-1.802	-2.303	-1.945
Free Cash Flow Per Share	N/A	-1.727	-1.119	-1.366	-1.725	-2.366	-2.02

Liquidity Ratios

Year End December 30 2023	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	26.25M	121.48M	124.27M	140.47M	142.62M	144.44M	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	144.44M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-189815.385	N/A	N/A	N/A	-295454.545	N/A	N/A
Net Profit Margin (%)	N/A	-189815.385	N/A	N/A	N/A	-295454.545	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	399.43M
Price to Earnings Ratio	-1.15
Price to Sales Ratio	3.58k
Price to Cash Ratio	4.51
Price to Book Ratio	0.73
Dividend Yield	-

Share Statistics

Shares Outstanding	209.67M
Average Volume (1 week)	2.86M
Average Volume (1 Month)	2.47M
52 Week Change	-39.15%
52 Week High	5.775
52 Week Low	1.7801

More Ratios Coming Soon!

Allogene Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions